Swiss Auto Components Stock News

SWX:LOGN
SWX:LOGNTech

Is Logitech International (SWX:LOGN) Cheap Following Q1 Results And New Sales Guidance?

Logitech International (SWX:LOGN) has drawn fresh attention after reporting first quarter 2026 results alongside new second quarter 2027 sales guidance, giving investors updated figures on current performance and near term expectations. See our latest analysis for Logitech International. Logitech International's share price has climbed 10.3% over the past 30 days and 7.4% year to date to CHF85.34, while its 3 year total shareholder return of 50.9% contrasts with a 5 year total shareholder...
SWX:KARN
SWX:KARNMachinery

Does Kardex’s 2026 Growth and Margin Guidance Change The Bull Case For Kardex Holding (SWX:KARN)?

Kardex Holding AG reported half-year 2026 results showing sales rising to €440.5 million from €415.7 million, while net income and earnings per share from continuing operations declined compared with a year earlier. Shortly after these results, Kardex issued 2026 guidance pointing to double-digit revenue growth and a mid‑single‑digit to low‑double‑digit EBIT margin, giving investors new insight into its operational ambitions and cost profile. We’ll now explore how Kardex’s updated 2026...
SWX:UBSG
SWX:UBSGCapital Markets

UBS Group (SWX:UBSG) Faces $125 Million U.S. Anti Money Laundering Fine

UBS Group subsidiary fined $125 million by multiple U.S. regulators for repeated anti money laundering violations. Penalties follow admissions that the bank failed to properly monitor foreign currency wire transfers and file suspicious activity reports. The settlement ranks among the larger recent anti money laundering cases involving a global financial institution. For investors tracking UBS Group, ticker SWX:UBSG, this enforcement action arrives while the stock trades around CHF42.55. The...
SWX:SWON
SWX:SWONElectronic

Global Market Highlights 3 Stocks Estimated Below Fair Value

Amid a week of mixed performances in major global indices, driven by central bank decisions and geopolitical tensions, investors are keenly observing market dynamics to identify potential opportunities. In such an environment, stocks estimated to be trading below their fair value can offer attractive prospects for those looking to capitalize on market inefficiencies.
SWX:HOLN
SWX:HOLNBasic Materials

Holcim (SWX:HOLN) Stock Faces A Valuation Puzzle After Profit Reset

Holcim stock closed at CHF73.34 on the day of the results and has drifted slightly lower over the past week. The market reaction looks muted for a company that just reported mid single digit organic net sales growth and double digit organic recurring EBIT growth in the first half. The real story is not today’s small move in the share price. It is how investors weigh that earnings power against a P/E above 100x that is anchored in a year affected by a CHF1.3b one off loss. Is Holcim a genuine...
SWX:ZEHN
SWX:ZEHNBuilding

Zehnder Group (SWX:ZEHN) Profit Recovery Raises Fresh Questions Over Margin Durability

Zehnder Group stock closed at CHF67.70 on Friday after a steady run over the past month. Yet the real story sits in the income statement rather than the ticker. The latest half year numbers put a bright spotlight on profitability. Net profit margin now stands at 6% compared with 2.4% a year earlier and earnings over the past 12 months are sharply higher. That kind of margin rebuild matters more than a single day’s move. For long term investors in building ventilation and climate systems, the...
SWX:BUCN
SWX:BUCNMachinery

Bucher Industries (SWX:BUCN) Stock Looks Cheap But Margins Are Cracking

Bucher Industries stock closed at CHF316 after a choppy week that left shares down about 4.5% over seven days, even as the latest half year numbers landed. The market focused on softer profit metrics more than the headline revenue figure of CHF1,471.4m for H1 2026. Net income of CHF87.5m and basic earnings per share of CHF8.90 point to a profit squeeze that matters far more than a single day price move. For long term holders, the key question now is how this margin pressure fits with the...
SWX:ASCN
SWX:ASCNHealthcare Services

Ascom Holding (SWX:ASCN) Stock Eyes Margin Recovery As Revenue Stays Flat

Ascom Holding came into this earnings day with a stock that had drifted, down around 11% over the past month and slightly weaker over the past week, while trading on a single digit P/E multiple. The H1 2026 numbers did not bring a flashy revenue surge, but they did show what matters most here. Profitability is quietly tightening, with basic earnings per share at CHF0.16 for the half and trailing net profit margin at 6.3%. The key point is that profit quality is improving while the market...
SWX:AUTN
SWX:AUTNAuto Components

Autoneum (SWX:AUTN) Stock Holds Earnings Strength Against Debt Concerns

Autoneum Holding stock closed at CHF130.40 on 30 July, capping a strong run over the past month. Yet the real story in these H1 2026 results is not the share price. It is how a relatively low P/E of 12.3x sits beside a double digit trailing twelve month earnings per share of CHF10.60. For short term traders, the move has already happened. For longer term holders, the key question now is how to weigh that earnings power and modest 2.7% net profit margin against high debt and an uneven dividend...
SWX:SIKA
SWX:SIKAChemicals

Sika (SWX:SIKA) Lifts Sales Outlook As Investors Revisit Whether The Shares Are Fully Valued

Sika (SWX:SIKA) drew fresh attention after its half year 2026 results, which showed broadly steady sales and earnings in Swiss francs, along with an upgrade to full year local currency sales guidance. See our latest analysis for Sika. The recent half year 2026 update seems to have shifted sentiment around Sika, with the stock showing a 7 day share price return of 13.86% and a 90 day share price return of 24.88%. However, the 1 year total shareholder return is down 6.31% and the 5 year total...
SWX:ROP
SWX:ROPPharmaceuticals

Roche (SWX:ROP) Wins FDA Clearance And EU Backing For Two Key Products

Roche Holding (SWX:ROP) received FDA 510(k) clearance for its cobas BV/CV molecular diagnostic assay, expanding its sexual health testing portfolio in the United States. The assay is designed to support more accurate diagnosis of bacterial vaginosis and vulvovaginal candidiasis, two common women's health conditions that are often misdiagnosed. The EMA’s Committee for Medicinal Products for Human Use issued a positive opinion for Susvimo, a ranibizumab implant for neovascular age related...
SWX:SCHN
SWX:SCHNMachinery

Schindler Holding (SWX:SCHN) Could Be 18% Below Fair Value As Guidance Holds

Schindler Holding (SWX:SCHN) reaffirmed its 2026 earnings guidance and released half-year results, giving investors fresh detail on how Modernization, Service and New Installations are shaping the company’s revenue profile this year. See our latest analysis for Schindler Holding. The reaffirmed guidance and higher earnings come against a mixed share price picture for Schindler Holding, with the stock down 12.11% on a year-to-date share price return and the 1-year total shareholder return also...
SWX:UBSG
SWX:UBSGCapital Markets

UBS Stock And 2 Banking Leaders for an AI Correction and Dealmaking Rebound

UBS has just put fresh attention on capital markets and investment banking after reporting Q2 pre tax profits of US$3.6b, up 64% year on year, alongside a new US$3b share buyback. The CEO also called the recent AI pullback a healthy correction and pointed to strong M&A and IPO activity, even as geopolitical risks linger. For investors, that mix of solid earnings, active deal flow and an AI reset could be significant. This article walks through 3 stocks exposed to those same news drivers and...
SWX:NESN
SWX:NESNFood

Did Nestlé’s (SWX:NESN) Peranel Joint Venture Just Reframe Its Capital Allocation Story?

Nestlé SA recently announced a plan to create Peranel, a 50:50 joint venture with Platinum Equity for its waters and premium beverages business, valuing the new company at about €4.90 billion and implying roughly €3.00 billion in cash proceeds for Nestlé when the deal closes, while also reporting half‑year 2026 sales of CHF43,109 million and net income of CHF3,472 million, both lower than a year earlier. The joint venture carves out more than 30 water and premium beverage brands into a...